On this page:

• Executive Committee
• Administrative Leadership
• Core Directors
• Deans and Directors
• External Scientific Advisory Board
• Community Advisory Board

Executive Committee

The Executive Committee provides leadership in the strategic planning and implementation of Masonic Cancer Center goals and objectives. It is responsible for formulating, directing, revising and implementing research, educational objectives, budget priorities, distribution of space and recruitment of faculty and staff.

Douglas Yee, M.D., Director and Program Co-Leader, Women's Cancer Research
Philip McGlave, M.D., Deputy Director
John Kersey, M.D., Founding Director Emeritus
Dorothy Hatsukami, Ph.D., Associate Director, Cancer Prevention and Control
Tucker LeBien, Ph.D., Associate Director, Basic Science
Jeffrey Miller, M.D., Associate Director, Experimental Therapeutics
David Rothenberger, M.D., Associate Director, Clinical Affairs
Mary Sumpmann, M.S., Associate Director, Administration
Selwyn Vickers, M.D., Associate Director, Translational Research
Levi Downs, M.D., Program Co-Leader, Women's Cancer Research
Stephen Hecht, Ph.D., Program Leader, Carcinogenesis and Chemoprevention
Anne Joseph, M.D., M.P.H., Program Co-Leader, Prevention and Etiology
David Largaespada, Ph.D., Program Leader, Genetic Mechanisms
of Cancer
DeAnn Lazovich, Ph.D., M.P.H. , Program Co-Leader, Prevention
and Etiology
James McCarthy, Ph.D., Program Leader, Tumor Biology and Progression
Joseph Neglia, M.D., M.P.H., Program Co-Leader, Cancer Outcomes and Survivorship
Yoji Shimizu, Ph.D., Program Leader, Immunology
Beth Virnig, Ph.D., Program Co-Leader, Cancer Outcomes and Survivorship
John Wagner, M.D., Program Co-Leader, Transplant Biology and Therapy
Daniel Weisdorf, M.D., Program Co-Leader, Transplant Biology and Therapy

Administrative Leadership

Marva Bohen, R.N., Outreach Director
Susan Collins, Finance and Operations Director
Sabine Fritz, Research Facilities Coordinator
Jean Jacoby, Executive Assistant for Administration
Charleen Pagel Jue, Program Manager, Clinical Trials Office
Mary Lawson, Public Relations Director
Mary Sumpmann, R.N., M.S., Associate Director for Administration

Shared Resource Directors

Cathy Carlson, D.V.M., Ph.D., Comparative Pathology
Anindya Bagchi, Ph.D., Mouse Genetics Laboratory (Co-Director)
Sabine Fritz, Laboratory Services
Eileen Harwood, Health Survey Research Center
Stephen S. Hecht, Ph.D., Analytical Biochemistry
Betsy Hirsch, Ph.D., Cytogenetics
David A. Largaespada, Ph.D., Mouse Genetics Laboratory (Co-Director)
Chap Le, Ph.D., Biostatistics and Informatics
Tucker LeBien, Ph.D., Flow Cytometry
Philip McGlave, M.D., Clinical Trials Office (Interim)
Amy Skubitz, Ph.D., Tissue Procurement Facility
Jeffrey Miller, M.D., Translational Cell Therapy

Deans and Directors

The Council of Deans and Directors advises the Director and assists in efforts to achieve goals and objectives, discusses advocacy for development and operations, and provides oversight of finances.

Frank Cerra, M.D., Chair, Senior Vice President, Academic Health Center; Dean, Medical School
Trevor Ames, D.V.M., Interim Dean, College of Veterinary
Medicine
Steven L. Crouch, Ph.D., Dean, Institute of Technology
Connie White Delaney, Ph.D., R.N., Dean, School of Nursing
Robert Elde, Ph.D., Dean, College of Biological Sciences
John Finnegan, Ph.D., Dean, School of Public Health
Patrick Lloyd, D.D.S., M.S., Dean, School of Dentistry
Marilyn Speedie, Ph.D., Dean, College of Pharmacy
Douglas Yee, M.D., Director, Masonic Cancer Center
Mary Sumpmann, R.N., M.S., (ex officio) Associate Director for Administration

External Scientific Advisory Board

The External Scientific Advisory Board, which consists of national experts in basic, clinical and population-based research, participates in an annual external scientific review of the Masonic Cancer Center's activities.

Irwin Bernstein, M.D., Hematology-Oncology Division Head, Fred Hutchinson Cancer Research Center, Seattle

Melissa Bondy, Ph.D., Professor, Department of Epidemiology, M.D. Anderson Cancer Center, Houston

Lisa Coussens, Ph.D., Associate Professor, Cancer Research Institute and Anatomic Pathology, University of California, San Francisco

William Dove, Ph.D., Professor of Oncology and Medical Genetics, University of Wisconsin-Madison

Ronald Herberman, M.D., Director, University of Pittsburgh Cancer Institute

Laurence Hurley, Ph.D., Howard J. Schaffer Endowed Chair in Pharmaceutical Sciences, College of Pharmacy, The University of Arizona

James Mulè, Ph.D., Associate Center Director, Translational Science & Tehncology Development, H. Lee Moffitt Cancer & Research Institute, Tampa

Mace Rothenberg, M.D., Professor of Medicine, Hematology/ Oncology Division Vanderbilt University, Nashville

Glorian Sorensen, Ph.D., M.P.H., Director, Center for Community-Based Research, Dana-Farber Cancer Institute

Marcy Waldinger, M.H.S.A., Chief Administrative Officer, University of Michigan Comprehensive Cancer Center

Gerald N. Wogan, Ph.D., Underwood Prescott Professor of Toxicology and Professor of Chemistry Emeritus, Division of Biological Engineering, Massachusetts Institute of Technology

Community Advisory Board

The Community Advisory Board advises and supports the leadership in mission, programmatic direction, community interactions, long-range finance and development strategies, outreach, public relations, and advocacy.

Dr. Thomas Amatruda
Ruth Bachman
Carla Bender
Idelle Bjelland
Dr. Stuart Bloom
Dr. John H. Brown
Marilyn T. Bryant
Barbara Burwell
Martin Chorzempa (Chair)
Jo DeBruycker
Barbara Forster (Past Chair)
Mark Gaasedelen
Kathleen Gavin
Bob Griffin
Ann Hengel
Dr. Wilhelmina Holder
Dr. Phyllis Kahn
Dr. James Krook
Roger Ledding
Dr. Irving Lerner
Don Mertz
Christine Roberts
Dennis W. Schulstad
George "Skip" Thaler
Joel Theisen
Emily Anne Tuttle
Win Wallin
Dr. Harold Windschitl
Janet Smith Yee
Dr. Douglas Yee*
Marva Bohen**
Mary Lawson**
Catherine McGlinch**
Mary Sumpmann**

*ex officio
** staff